Yale Study: Prevalence of Artificial Sweetener Neotame in US-Marketed Disposable E-Cigarettes | Newswise

Yale Study: Prevalence of Artificial Sweetener Neotame in US-Marketed Disposable E-Cigarettes | Newswise

Newswise — When researchers from Yale School of Medicine and Duke University analyzed numerous brands of popular vaping products, they found that a majority contained neotame, an artificial sweetener that is 7,000-13,000 times sweeter than table sugar. In addition to concerns about whether the chemical is contained in many products, little to nothing is known…

Read More
Olympic Anti-Doping Lab Puts U.S. Meat Supply to the Test | Newswise

Olympic Anti-Doping Lab Puts U.S. Meat Supply to the Test | Newswise

Newswise — Scientists at UCLA’s Olympic Analytical Laboratory turned their sophisticated analytical capabilities for testing athlete samples for performance-enhancing drugs to research examining the U.S. meat supply as part of a study led by Texas Tech. The study was designed to investigate concerns that residues of growth promoters used in meat production could potentially cause…

Read More
Yale Study: Prevalence of Artificial Sweetener Neotame in US-Marketed Disposable E-Cigarettes | Newswise

Enhanced Recovery Pathways Slash Opioid Prescriptions in Iowa Hospitals | Newswise

Newswise — A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways. The study, led by researchers from the Rothman Opioid Foundation, Goldfinch Health, and Drexel University College of Medicine, examined the impact of ERAS protocols on opioid prescribing to…

Read More
Compound Harnesses Cannabis’ Pain-Relieving Properties Without Side Effects | Newswise

Compound Harnesses Cannabis’ Pain-Relieving Properties Without Side Effects | Newswise

Newswise — Treatment for chronic pain still relies heavily on opioids. While effective, they are highly addictive and potentially deadly if misused. In the quest to develop a safe, effective alternative to opioids, researchers at Washington University School of Medicine in St. Louis and Stanford University have developed a compound that mimics a natural molecule found…

Read More
LLNL Scientists Use AI to Optimize Antibodies to Combat Future Mutations and Accelerate Pandemic Preparedness | Newswise

LLNL Scientists Use AI to Optimize Antibodies to Combat Future Mutations and Accelerate Pandemic Preparedness | Newswise

Newswise — Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants. This pioneering approach, published in the journal Science Advances, represents a significant leap in the fight against rapidly evolving viruses such…

Read More
Yale Study: Prevalence of Artificial Sweetener Neotame in US-Marketed Disposable E-Cigarettes | Newswise

Emergency Clinicians Increase Prescriptions of Buprenorphine, Effectively Helping Patients Get Started on the Path to Recovery | Newswise

Newswise — In the face of the alarming number of opioid-related deaths in the U.S., there have been national efforts to increase emergency clinician prescribing of buprenorphine, a medication used to treat opioid use disorder. In a new study published in JAMA, UCLA Health researchers report on the extent and success rate of such efforts…

Read More
MD Anderson Researchers Develop Novel Antibody-Toxin Conjugate | Newswise

MD Anderson Researchers Develop Novel Antibody-Toxin Conjugate | Newswise

Newswise — HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies. ADCs have…

Read More
Yale Study: Prevalence of Artificial Sweetener Neotame in US-Marketed Disposable E-Cigarettes | Newswise

Surgeons Detail Challenges in Treating ‘Tranq’ Wounds Amid Philadelphia’s Xylazine Crisis | Newswise

Newswise — A new study examining the treatment of xylazine-associated wounds in Philadelphia sheds light on the severe medical complications and healthcare challenges caused by the widespread presence of the drug in the city’s illicit supply. Conducted by surgeons at Cooper University Hospital and researchers from Drexel University College of Medicine and the Philadelphia College…

Read More
New Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier | Newswise

New Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier | Newswise

Newswise — New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier. The findings, in mouse models…

Read More